TY - JOUR
T1 - Impaired lymphocyte reconstitution after autologous transplant is associated with apoptosis of CD8+ T cells and adverse clinical outcome
AU - Rozovski, Uri
AU - Naparstek, Ella
AU - Frank, Shani
AU - Fourman, Alexey
AU - Zigman-Hoffman, Eti
AU - Bleiberg, Margalit
AU - Yeshurun, Moshe
AU - Trestman, Svetlana
AU - Tartakovsky, Boris
N1 - Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/9
Y1 - 2019/9
N2 - We noticed that the lymphocyte counts, after autologous hematopoietic stem cell transplantation, oscillated during the first 4 post-transplant months. Thereafter, the lymphocyte counts stabilized and segregated the patients into two groups, those who normalized their lymphocyte counts and those with prolonged lymphopenia. In both groups, the CD4 counts remained low for at least 6 months. However, in approximately half of the patient, the CD8 counts increased to normal or above normal values. Patients with prolonged lymphopenia had higher rates of lymphocytes’ spontaneous apoptosis and the lymphocytes in patients who restored their counts expressed the intracellular CD14-derived MO2 epitope that protects the cells from apoptosis. These findings were translated to longer disease-free survival and overall survival in patients who restored the CD8 counts. Collectively, our data show that post-transplant lymphocytes that express intracellular CD14-MO2 epitope have survival advantage.
AB - We noticed that the lymphocyte counts, after autologous hematopoietic stem cell transplantation, oscillated during the first 4 post-transplant months. Thereafter, the lymphocyte counts stabilized and segregated the patients into two groups, those who normalized their lymphocyte counts and those with prolonged lymphopenia. In both groups, the CD4 counts remained low for at least 6 months. However, in approximately half of the patient, the CD8 counts increased to normal or above normal values. Patients with prolonged lymphopenia had higher rates of lymphocytes’ spontaneous apoptosis and the lymphocytes in patients who restored their counts expressed the intracellular CD14-derived MO2 epitope that protects the cells from apoptosis. These findings were translated to longer disease-free survival and overall survival in patients who restored the CD8 counts. Collectively, our data show that post-transplant lymphocytes that express intracellular CD14-MO2 epitope have survival advantage.
KW - Lymphocytes
KW - basic biology
KW - cell cycle and apoptosis changes
UR - http://www.scopus.com/inward/record.url?scp=85060207804&partnerID=8YFLogxK
U2 - 10.1080/10428194.2018.1563696
DO - 10.1080/10428194.2018.1563696
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 30656985
AN - SCOPUS:85060207804
SN - 1042-8194
VL - 60
SP - 2264
EP - 2270
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 9
ER -